Abstract
Clinical and laboratory data on the treatment of 19 children with chronic toxoplasmosis were used for estimation of the efficacy of drug combination, such as spiramycin + lidase and lincomycin + lidase vs. the traditional therapy (co-trimoxazole, metronidazole). The combination designed by us, i.e. spiramycin + lidase, lincomycin + lidase used in consecutive courses proved to be more efficient.
Publication types
-
Clinical Trial
-
Comparative Study
-
English Abstract
-
Randomized Controlled Trial
MeSH terms
-
Administration, Oral
-
Child
-
Chronic Disease
-
Coccidiostats / administration & dosage
-
Coccidiostats / therapeutic use*
-
Drug Therapy, Combination
-
Humans
-
Hyaluronoglucosaminidase / administration & dosage
-
Hyaluronoglucosaminidase / therapeutic use*
-
Injections, Intramuscular
-
Lincomycin / administration & dosage
-
Lincomycin / therapeutic use*
-
Spiramycin / administration & dosage
-
Spiramycin / therapeutic use*
-
Toxoplasmosis / drug therapy*
Substances
-
Coccidiostats
-
Spiramycin
-
Lincomycin
-
lidase
-
Hyaluronoglucosaminidase